Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Who accepts and who uses community-based secondary distribution HIV self-testing (HIVST) kits? Findings from the intervention arm of a cluster-randomised trial of HIVST distribution nested in four HPTN 071 (PopART) communities in Zambia.

Hensen B, Schaap AJ, Mulubwa C, Floyd S, Shanaube K, Phiri M, Bond V, Bwalya C, Simwinga M, Fidler S, Hayes R, Mwinga A, Ayles H.

J Acquir Immune Defic Syndr. 2020 Mar 13. doi: 10.1097/QAI.0000000000002344. [Epub ahead of print]

PMID:
32195749
2.

What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?

Havlir D, Lockman S, Ayles H, Larmarange J, Chamie G, Gaolathe T, Iwuji C, Fidler S, Kamya M, Floyd S, Moore J, Hayes R, Petersen M, Dabis F; (Universal Test, Treat Trials) UT3 Consortium.

J Int AIDS Soc. 2020 Feb;23(2):e25455. doi: 10.1002/jia2.25455.

3.

Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART).

Eshleman SH, Piwowar-Manning E, Wilson EA, Lennon D, Fogel JM, Agyei Y, Sullivan PA, Weng L, Moore A, Laeyendecker O, Kosloff B, Bwalya J, Maarman G, van Deventer A, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Donnell D; HPTN 071 (PopART) Study Team.

J Int AIDS Soc. 2020 Feb;23(2):e25452. doi: 10.1002/jia2.25452.

4.

Stigma and Judgment Toward People Living with HIV and Key Population Groups Among Three Cadres of Health Workers in South Africa and Zambia: Analysis of Data from the HPTN 071 (PopART) Trial.

Krishnaratne S, Bond V, Stangl A, Pliakas T, Mathema H, Lilleston P, Hoddinott G, Bock P, Ayles H, Fidler S, Hargreaves JR.

AIDS Patient Care STDS. 2020 Jan;34(1):38-50. doi: 10.1089/apc.2019.0131.

PMID:
31944852
5.

Development of parallel measures to assess HIV stigma and discrimination among people living with HIV, community members and health workers in the HPTN 071 (PopART) trial in Zambia and South Africa.

Stangl AL, Lilleston P, Mathema H, Pliakas T, Krishnaratne S, Sievwright K, Bell-Mandla N, Vermaak R, Mainga T, Steinhaus M, Donnell D, Schaap A, Bock P, Ayles H, Hayes R, Hoddinott G, Bond V, Hargreaves JR; HPTN 071 (PopART) Study Team.

J Int AIDS Soc. 2019 Dec;22(12):e25421. doi: 10.1002/jia2.25421.

6.

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Tait DR, Hatherill M, Van Der Meeren O, Ginsberg AM, Van Brakel E, Salaun B, Scriba TJ, Akite EJ, Ayles HM, Bollaerts A, Demoitié MA, Diacon A, Evans TG, Gillard P, Hellström E, Innes JC, Lempicki M, Malahleha M, Martinson N, Mesia Vela D, Muyoyeta M, Nduba V, Pascal TG, Tameris M, Thienemann F, Wilkinson RJ, Roman F.

N Engl J Med. 2019 Dec 19;381(25):2429-2439. doi: 10.1056/NEJMoa1909953. Epub 2019 Oct 29.

PMID:
31661198
7.

Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review.

Gupta N, Ayles HM.

Eur J Health Econ. 2019 Dec;20(9):1303-1315. doi: 10.1007/s10198-019-01097-4. Epub 2019 Aug 10.

PMID:
31401699
8.

Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).

Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, Emel L, Macleod D, Dunbar R, Simwinga M, Makola N, Bond V, Hoddinott G, Moore A, Griffith S, Deshmane Sista N, Vermund SH, El-Sadr W, Burns DN, Hargreaves JR, Hauck K, Fraser C, Shanaube K, Bock P, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.

N Engl J Med. 2019 Jul 18;381(3):207-218. doi: 10.1056/NEJMoa1814556.

9.

Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis.

Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Wilson D, Jani I, Apollo T, Sculpher M, Hallett T, Kerr C, van Oosterhout JJ, Eaton JW, Estill J, Williams B, Doi N, Cowan F, Keiser O, Ford D, Hatzold K, Barnabas R, Ayles H, Meyer-Rath G, Nelson L, Johnson C, Baggaley R, Fakoya A, Jahn A, Revill P.

J Int AIDS Soc. 2019 Jul;22(7):e25325. doi: 10.1002/jia2.25325.

10.

Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.

Siddiqi OK, Birbeck GL, Ghebremichael M, Mubanga E, Love S, Buback C, Kosloff B, Ayles H, Atadzhanov M, Dheda K, Koralnik IJ.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00652-19. doi: 10.1128/JCM.00652-19. Print 2019 Aug.

11.

Development and validation of a prediction model for active tuberculosis case finding among HIV-negative/unknown populations.

Shih YJ, Ayles H, Lönnroth K, Claassens M, Lin HH.

Sci Rep. 2019 Apr 16;9(1):6143. doi: 10.1038/s41598-019-42372-x.

12.

Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.

Bock P, Nel K, Fatti G, Sloot R, Ford N, Voget J, Gunst C, Grobbelaar N, Louis F, Floyd S, Hayes R, Ayles H, Beyers N, Fidler S; HPTN 071 (PopART) Team.

HIV Med. 2019 Jul;20(6):392-403. doi: 10.1111/hiv.12729. Epub 2019 Apr 8.

13.

Work and home productivity of people living with HIV in Zambia and South Africa.

Thomas R, Friebel R, Barker K, Mwenge L, Kanema S, Vanqa N, Harper A, Bell-Mandla N, Smith PC, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Hauck K; HPTN 071 (PopART) Study Team.

AIDS. 2019 May 1;33(6):1063-1071. doi: 10.1097/QAD.0000000000002160.

14.

Re-reading of OraQuick HIV-1/2 rapid antibody test results: quality assurance implications for HIV self-testing programmes.

Watson V, Dacombe RJ, Williams C, Edwards T, Adams ER, Johnson CC, Mutseta MN, Corbett EL, Cowan FM, Ayles H, Hatzold K, MacPherson P, Taegtmeyer M.

J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25234. doi: 10.1002/jia2.25234.

15.

Economic cost analysis of door-to-door community-based distribution of HIV self-test kits in Malawi, Zambia and Zimbabwe.

Mangenah C, Mwenge L, Sande L, Ahmed N, d'Elbée M, Chiwawa P, Chigwenah T, Kanema S, Mutseta MN, Nalubamba M, Chilongosi R, Indravudh P, Sibanda EL, Neuman M, Ncube G, Ong JJ, Mugurungi O, Hatzold K, Johnson CC, Ayles H, Corbett EL, Cowan FM, Maheswaran H, Terris-Prestholt F.

J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25255. doi: 10.1002/jia2.25255.

16.

Ability to understand and correctly follow HIV self-test kit instructions for use: applying the cognitive interview technique in Malawi and Zambia.

Simwinga M, Kumwenda MK, Dacombe RJ, Kayira L, Muzumara A, Johnson CC, Indravudh P, Sibanda EL, Nyirenda L, Hatzold K, Corbett EL, Ayles H, Taegtmeyer M.

J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25253. doi: 10.1002/jia2.25253.

17.

Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa.

Fatti G, Grimwood A, Nachega JB, Nelson JA, LaSorda K, van Zyl G, Grobbelaar N, Ayles H, Hayes R, Beyers N, Fidler S, Bock P.

Clin Infect Dis. 2020 Jan 16;70(3):395-403. doi: 10.1093/cid/ciz214.

18.

Application of an HIV Prevention Cascade to Identify Gaps in Increasing Coverage of Voluntary Medical Male Circumcision Services in 42 Rural Zambian Communities.

Hensen B, Fearon E, Schaap A, Lewis JJ, Weiss HA, Tembo M, Chintu N, Ayles H, Hargreaves JR.

AIDS Behav. 2019 May;23(5):1095-1103. doi: 10.1007/s10461-019-02407-w.

PMID:
30737610
19.

Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communities.

Mulubwa C, Hensen B, Phiri MM, Shanaube K, Schaap AJ, Floyd S, Phiri CR, Bwalya C, Bond V, Simwinga M, Mwenge L, Fidler S, Hayes R, Mwinga A, Ayles H; HPTN 071 (PopART) Study Team.

Lancet HIV. 2019 Feb;6(2):e81-e92. doi: 10.1016/S2352-3018(18)30258-3. Epub 2018 Dec 21.

20.

Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods.

Mwanza W, Milimo D, Chilufya MM, Kasese N, Lengwe MC, Munkondya S, de Haas P, Ayles H, Muyoyeta M.

Afr J Lab Med. 2018 Dec 6;7(2):806. doi: 10.4102/ajlm.v7i2.806. eCollection 2018.

21.

Value and Limitations of Broad Brush Surveys Used in Community-Randomized Trials in Southern Africa.

Bond V, Ngwenya F, Murray E, Ngwenya N, Viljoen L, Gumede D, Bwalya C, Mantantana J, Hoddinott G, Dodd PJ, Ayles H, Simwinga M, Wallman S, Seeley J.

Qual Health Res. 2019 Apr;29(5):700-718. doi: 10.1177/1049732318809940. Epub 2018 Dec 17.

22.

"Being seen" at the clinic: Zambian and South African health worker reflections on the relationship between health facility spatial organisation and items and HIV stigma in 21 health facilities, the HPTN 071 (PopART) study.

Bond V, Nomsenge S, Mwamba M, Ziba D, Birch A, Mubekapi-Musadaidzwa C, Vanqa N, Viljoen L, Pliakas T, Ayles H, Hargreaves J, Hoddinott G, Stangl A, Seeley J; HPTN 071 (PopART) study team.

Health Place. 2019 Jan;55:87-99. doi: 10.1016/j.healthplace.2018.11.006. Epub 2018 Dec 7.

23.

Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa.

Seeley J, Bond V, Yang B, Floyd S, MacLeod D, Viljoen L, Phiri M, Simuyaba M, Hoddinott G, Shanaube K, Bwalya C, de Villiers L, Jennings K, Mwanza M, Schaap A, Dunbar R, Sabapathy K, Ayles H, Bock P, Hayes R, Fidler S; HPTN 071 (PopART) study team.

AIDS Behav. 2019 Apr;23(4):929-946. doi: 10.1007/s10461-018-2335-7.

24.

The effectiveness and cost-effectiveness of community-based lay distribution of HIV self-tests in increasing uptake of HIV testing among adults in rural Malawi and rural and peri-urban Zambia: protocol for STAR (self-testing for Africa) cluster randomized evaluations.

Neuman M, Indravudh P, Chilongosi R, d'Elbée M, Desmond N, Fielding K, Hensen B, Johnson C, Mkandawire P, Mwinga A, Nalubamba M, Ncube G, Nyirenda L, Nyrienda R, Kampe EOI, Taegtmeyer M, Terris-Prestholt F, Weiss HA, Hatzold K, Ayles H, Corbett EL.

BMC Public Health. 2018 Nov 6;18(1):1234. doi: 10.1186/s12889-018-6120-3.

25.

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, Muyoyeta M, Van Brakel E, Ayles HM, Henostroza G, Thienemann F, Scriba TJ, Diacon A, Blatner GL, Demoitié MA, Tameris M, Malahleha M, Innes JC, Hellström E, Martinson N, Singh T, Akite EJ, Khatoon Azam A, Bollaerts A, Ginsberg AM, Evans TG, Gillard P, Tait DR.

N Engl J Med. 2018 Oct 25;379(17):1621-1634. doi: 10.1056/NEJMoa1803484. Epub 2018 Sep 25.

26.

Associations between health systems capacity and mother-to-child HIV prevention program outcomes in Zambia.

Price JT, Chi BH, Phiri WM, Ayles H, Chintu N, Chilengi R, Stringer JSA, Mutale W.

PLoS One. 2018 Sep 7;13(9):e0202889. doi: 10.1371/journal.pone.0202889. eCollection 2018.

27.

Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.

Floyd S, Ayles H, Schaap A, Shanaube K, MacLeod D, Phiri M, Griffith S, Bock P, Beyers N, Fidler S, Hayes R; HPTN 071 (PopART) Study Team.

PLoS One. 2018 Aug 10;13(8):e0197904. doi: 10.1371/journal.pone.0197904. eCollection 2018.

28.

Households, fluidity, and HIV service delivery in Zambia and South Africa - an exploratory analysis of longitudinal qualitative data from the HPTN 071 (PopART) trial.

Hoddinott G, Myburgh H, de Villiers L, Ndubani R, Mantantana J, Thomas A, Mbewe M, Ayles H, Bock P, Seeley J, Shanaube K, Hargreaves J, Bond V, Reynolds L; HPTN 071 (PopART) Study Team.

J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25135. doi: 10.1002/jia2.25135.

29.

Spinning plates: livelihood mobility, household responsibility and anti-retroviral treatment in an urban Zambian community during the HPTN 071 (PopART) study.

Bond V, Ngwenya F, Thomas A, Simuyaba M, Hoddinott G, Fidler S, Hayes R, Ayles H, Seeley J; HPTN 071 (PopART) study team.

J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25117. doi: 10.1002/jia2.25117.

30.

Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and Zambia.

d'Elbée M, Indravudh PP, Mwenge L, Kumwenda MM, Simwinga M, Choko AT, Hensen B, Neuman M, Ong JJ, Sibanda EL, Johnson CC, Hatzold K, Cowan FM, Ayles H, Corbett EL, Terris-Prestholt F.

AIDS. 2018 Sep 10;32(14):2043-2049. doi: 10.1097/QAD.0000000000001918.

31.

Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.

Bock P, Fatti G, Ford N, Jennings K, Kruger J, Gunst C, Louis F, Grobbelaar N, Shanaube K, Floyd S, Grimwood A, Hayes R, Ayles H, Fidler S, Beyers N; HPTN 071 (PopART) trial team.

PLoS One. 2018 Apr 19;13(4):e0195127. doi: 10.1371/journal.pone.0195127. eCollection 2018.

32.

Sexually Transmitted Bedfellows: Exquisite Association Between HIV and Herpes Simplex Virus Type 2 in 21 Communities in Southern Africa in the HIV Prevention Trials Network 071 (PopART) Study.

Bradley J, Floyd S, Piwowar-Manning E, Laeyendecker O, Young A, Bell-Mandla N, Bwalya J, Bock P, Fidler S, Ayles H, Hayes RJ; HPTN 071 (PopART) Study Team.

J Infect Dis. 2018 Jul 2;218(3):443-452. doi: 10.1093/infdis/jiy178.

33.

Is home-based HIV testing universally acceptable? Findings from a case-control study nested within the HPTN 071 (PopART) trial.

Sabapathy K, Mulubwa C, Mathema H, Mubekapi-Musadaidzwa C, Schaap A, Hoddinott G, Hargreaves J, Floyd S, Ayles H, Hayes R; HPTN 071 (PopART) Study Team.

Trop Med Int Health. 2018 Jun;23(6):678-690. doi: 10.1111/tmi.13055. Epub 2018 Apr 16.

34.

Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.

Chi BH, Mutale W, Winston J, Phiri W, Price JT, Mwiche A, Ayles H, Stringer JSA.

Pediatr Infect Dis J. 2018 Nov;37(11):1137-1141. doi: 10.1097/INF.0000000000001997.

35.

Socio-economic gradients in prevalent tuberculosis in Zambia and the Western Cape of South Africa.

Yates TA, Ayles H, Leacy FP, Schaap A, Boccia D, Beyers N, Godfrey-Faussett P, Floyd S.

Trop Med Int Health. 2018 Apr;23(4):375-390. doi: 10.1111/tmi.13038. Epub 2018 Mar 24. Erratum in: Trop Med Int Health. 2018 Aug;23(8):934.

36.

Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: analysis of data from the HPTN071 (PopART) study.

Hargreaves JR, Krishnaratne S, Mathema H, Lilleston PS, Sievwright K, Mandla N, Mainga T, Vermaak R, Piwowar-Manning E, Schaap A, Donnell D, Ayles H, Hayes RJ, Hoddinott G, Bond V, Stangl A; HPTN 071 (PopART) Study Team.

AIDS. 2018 Mar 27;32(6):783-793. doi: 10.1097/QAD.0000000000001757.

37.

Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa.

Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H, Floyd S, Havlir D, Kamya M, Lebelonyane R, Mills LA, Okello V, Petersen M, Pillay D, Sabapathy K, Wirth K, Orne-Gliemann J, Dabis F; Universal Test and Treat Trials Consortium (UT3C).

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25048.

38.

Predictors of timely linkage-to-ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case-control study.

Sabapathy K, Mubekapi-Musadaidzwa C, Mulubwa C, Schaap A, Hoddinott G, Stangl A, Floyd S, Ayles H, Fidler S, Hayes R; HPTN 071 (PopART) study team.

J Int AIDS Soc. 2017 Dec;20(4). doi: 10.1002/jia2.25037.

39.

Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe.

Mwenge L, Sande L, Mangenah C, Ahmed N, Kanema S, d'Elbée M, Sibanda E, Kalua T, Ncube G, Johnson CC, Hatzold K, Cowan FM, Corbett EL, Ayles H, Maheswaran H, Terris-Prestholt F.

PLoS One. 2017 Oct 16;12(10):e0185740. doi: 10.1371/journal.pone.0185740. eCollection 2017.

40.

Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR).

Bond V, Floyd S, Fenty J, Schaap A, Godfrey-Faussett P, Claassens M, Shanaube K, Ayles H, Hargreaves JR.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):49-59. doi: 10.5588/ijtld.16.0920.

41.

Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.

Bock P, Jennings K, Vermaak R, Cox H, Meintjes G, Fatti G, Kruger J, De Azevedo V, Maschilla L, Louis F, Gunst C, Grobbelaar N, Dunbar R, Limbada M, Floyd S, Grimwood A, Ayles H, Hayes R, Fidler S, Beyers N.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):93-101. doi: 10.1097/QAI.0000000000001560.

42.

Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.

Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith PC, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K; HPTN 071 (PopART) Study Team.

Lancet Glob Health. 2017 Nov;5(11):e1133-e1141. doi: 10.1016/S2214-109X(17)30367-4. Epub 2017 Sep 27.

43.

Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa.

Bock P, Phiri C, Piwowar-Manning E, Kosloff B, Mandla N, Young A, James A, Schaap A, Scheepers M, Donnell D, Griffith S, El-Sadr W, Shanaube K, Beyers N, Hayes R, Fidler S, Ayles H; HPTN 071 (PopART) Study Team.

J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21780. doi: 10.7448/IAS.20.7.21780.

44.

Community intervention improves knowledge of HIV status of adolescents in Zambia: findings from HPTN 071-PopART for youth study.

Shanaube K, Schaap A, Chaila MJ, Floyd S, Mackworth-Young C, Hoddinott G, Hayes R, Fidler S, Ayles H; HPTN 071 (PopART) Study Team.

AIDS. 2017 Jul 1;31 Suppl 3:S221-S232. doi: 10.1097/QAD.0000000000001530.

45.

The sensitivity of the QuantiFERON®-TB Gold Plus assay in Zambian adults with active tuberculosis.

Telisinghe L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, Cheeba-Lengwe M, Chiwele K, Kosloff B, Floyd S, Bailey SL, Ayles H.

Int J Tuberc Lung Dis. 2017 Jun 1;21(6):690-696. doi: 10.5588/ijtld.16.0764.

46.

What works - reaching universal HIV testing: lessons from HPTN 071 (PopART) trial in Zambia.

Shanaube K, Schaap A, Floyd S, Phiri M, Griffith S, Chaila J, Bock P, Hayes R, Fidler S, Ayles H; HPTN 071 (PopART) Study Team.

AIDS. 2017 Jul 17;31(11):1555-1564. doi: 10.1097/QAD.0000000000001514.

47.

A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.

Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.

PLoS Med. 2017 May 2;14(5):e1002292. doi: 10.1371/journal.pmed.1002292. eCollection 2017 May.

48.

Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosis.

Muyoyeta M, Kasese NC, Milimo D, Mushanga I, Ndhlovu M, Kapata N, Moyo-Chilufya M, Ayles H.

BMC Infect Dis. 2017 Apr 24;17(1):301. doi: 10.1186/s12879-017-2388-7.

49.

Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.

Claassens MM, van Schalkwyk C, Floyd S, Ayles H, Beyers N.

PLoS One. 2017 Mar 3;12(3):e0172881. doi: 10.1371/journal.pone.0172881. eCollection 2017.

50.

Association between diabetes mellitus and active tuberculosis in Africa and the effect of HIV.

Bailey SL, Ayles H.

Trop Med Int Health. 2017 Mar;22(3):261-268. doi: 10.1111/tmi.12822. Epub 2017 Jan 9. Review.

Supplemental Content

Support Center